Six studies reported the mortality data for IPF in 22 countries, and 62 studies (covering 63 307 patients from 20 countries) reported survival data for IPF. Age-standardised mortality for IPF varied from ∼0.5 to ∼12 per 100 000 population per year after year 2000.

Jul 7, 2021 · Background: Idiopathic pulmonary fibrosis (IPF) is a progressive debilitating lung disease with considerable morbidity. Heterogeneity in epidemiologic studies means the full impact of the disease is unclear.

Mar 14, 2022 · Results: Six studies reported the mortality data for IPF in 22 countries, and 62 studies (covering 63 307 patients from 20 countries) reported survival data for IPF. Age-standardised mortality for IPF varied from ∼0.5 to ∼12 per …

Aug 1, 2021 · The leading cause of death in IPF patients was respiratory causes, followed by cancer. Among IPF patients, 37.8% (7417 of 18,905) died due to respiratory causes, which was about ten times higher than that in the control group (adjusted HR 9.743, p < 0.001).

Aug 6, 2018 · Globally, incidence of the disease is rising, with associated high morbidity, mortality, and economic healthcare burden. Diagnosis relies on a multidisciplinary team approach with exclusion of other causes of interstitial lung disease.

Mar 6, 2025 · During 2020–2022, a total of 67,843 deaths with IPF listed as the underlying (38,869; 57.3%) or a contributing (28,974; 42.7%) cause of death among U.S. residents aged ≥15 years were reported (Table 1), accounting for 0.7% of 9,738,271 deaths from all causes.

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lung disease of unknown cause, often with characteristic imaging and histological appearances, which occurs primarily in older adults [1].

Aug 13, 2020 · IPF-related deaths were identified using International Classification of Diseases, 10th revision, codes. We examined annual trends in age-adjusted mortality rates stratified by age, sex, race, and state of residence. We also evaluated trends in …

Jul 1, 2014 · Furthermore, IPF patients carry significant comorbidities including PH, cardiovascular disease, and lung cancer that worsen their QOL and survival. As the prevalence of IPF increases with our aging population, there is an increasing strain on healthcare resources.

Sep 1, 2023 · Idiopathic pulmonary fibrosis (IPF) is a progressive devastating lung disease with substantial morbidity. It is associated with cough, dyspnea and impaired quality of life. If left untreated, IPF has a median survival of 3 years.